This congress will be delivered as a hybrid (on-site or virtual) experience due to COVID-19 pandemic spread.
The 22nd Annual International Lung Cancer Congress® will distill the latest data on targeted agents, immunotherapy, surgery, and radiation oncology to provide participants with current and practical information on the management of patients with lung cancer. As in previous years, the organizers will also preview novel agents and strategies with the potential to shape the future of lung cancer therapy. The congress will provide an opportunity for participants to engage with leading international and national experts as they share their perspectives and personal experiences surrounding clinical challenges and ongoing controversies in lung cancer management.
Format: Cutting-edge lectures and extended panel discussions, along with multidisciplinary tumor boards and interactive Q&A sessions.
Hot Topics for 2021:
- Adjuvant EGFR-targeted therapy
- Choosing firstline immunotherapy-based regimens
- Targeted agents and the expanding array of oncogenic drivers
- Telemedicine and incorporating technology in the practice of oncology
Hyatt Regency Huntington Beach Resort and Spa
July 29-31, 2021
Huntington Beach, California 92648, United States